Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: June 3, 2026Bookmark

Overview

Infertility is the inability of a couple to conceive with regular intercourse (3-4 times per week) and in the absence of contraception after 12 months in women < 35 years and 6 months in women > 35 years. Infertility is not the same as **recurrent pregnancy loss.

Definition of terms

TermDefinition
Primary infertilityThe couple meets the definition of infertility and has never been able to conceive. Prevalence increases with the age of the female partner
Secondary infertilityThe couple meets the definition of infertility, but has conceived before
FecundabilityThe probability of achieving pregnancy in one cycle. Around 0.20-0.25. Lowers with increasing age of the female partner

Female Infertility

  • Common causes of infertility in women
    • Defective implantation due to endometrial dysfunction (fibroids, adhesions, polyps – 30%)
    • Anovulation (25%)
    • Tubal damage (20%)
    • Cervical scarring or dysfunction (5%)
    • Sexual dysfunction (5%)

Disorders of ovulation

GroupDescription
Group I – Hypothalamic failureHypogonadotropic hypogonadism caused by failure of the hypothalamus to produce sufficient FSH and LH, leading to no ovulation
Group II – Hypothalamic-pituitary-ovarian dysfunctionCommonly the result of PCOS. This is the most common cause of ovulation disorder. Excess androgens associated with PCOS inhibit ovulation
Group III – Ovarian failureHypergonadotropic hypogonadism due to insufficient follicles in the ovary

Causes of infertility in women

CausesExamples
OvulatoryHypothyroidism, HyperprolactinemiaPCOS, Premature ovarian failure, Diminished ovarian reserve (age, endometriosis), Wedge resection of the ovary, Functional hypothalamic amenorrhoea, Turner syndrome
TubalPID, Endometriosis, Pelvic adhesions/obstructions
UterineUterine fibroids, Endometrial polyps, Bicornuate uterus, Septate uterus, Asherman syndrome, Mayer-Rokitansky-Kuster-Hauser syndrome

Male Infertility

Causes of primary hypogonadism in men

CausesExamples
TesticularVaricocele, Mumps, Gonorrhea, Torsion, Cryptorchidism
GeneticKlinefelter syndrome, Y chromosome microdeletion

Causes of secondary hypogonadism in men

CauseExamples
Secondary hypogonadismHyperprolactinemia, Hypothyroidism, Liver cirrhosis, Obesity, Spironolactone, Cimetidine, Anabolic steroids, Prolonged glucocorticoid therapy, Kallman syndrome

Other causes of male infertility

CausesExamples
PsychosocialErectile dysfunction, impotence
Sperm abnormalitiesImmotile cilia syndrome

Evaluation of Infertility

  • Questions on conception
    • Has the couple been able to conceive before?
    • Has either member of the couple conceived before (with another partner)?
  • Menstrual history
    • Has she ever had a period? (rule out primary amenorrhoea)
    • Does she have regular periods?
    • How long are her cycles?
    • Does she have symptoms with her periods/ (e.g., cramping, bloating)
    • Are her periods painful? (dysmenorrhea = endometriosis)
  • Sexual history
    • When and how often is the couple having sex?
    • Is it painful?
    • What is his libido? (Low libido = androgen insensitivity)
    • When did each start puberty? (Should be at Tanner stage V)
    • History of STDs or genitourinary infections (PID)
  • Past medical history
    • Weight (extremes of BMI)
    • Chronic illnesses
    • Medications
  • Past surgical history
    • History of gynaecologic surgery (e.g., oophorectomy, dilation and curettage causing Asherman syndrome)
    • Has he had any genitourinary or inguinal surgery? (Vasectomy, Orchidectomy, Herniorrhaphy)
  • Social history
    • Alcohol
    • Drugs (including anabolic steroids)
    • Stress
  • Physical exam of the female partner
    • General exam: Abnormal body habitus, lack of secondary sex characteristics (breast, hair distribution)
    • Skin: Hirsutism, acne (PCOS)
    • HEENT: abnormalities of the thyroid gland, male pattern balding (PCOS)
    • Breast: underdeveloped, expressable milk from nipples
    • Abdomen: abdominal striae, truncal obesity
    • Pelvic exam
      • External: lack of pubic hair
      • Vaginal/cervical: lack of a patent cervix, double cervix
      • Uterine/adenxal: Structural (Mullerian) abnormalities, leiomyomas, retroversion, tender nodules
  • Physical exam of the male partner
    • General exam: Eunuchoidal habitus (long arms and legs; upper/lower body ratio < 1); obesity and decreased muscle mass
    • Skin: absence or loss of axillary and facial hair
    • Breast: Gynecomastia
    • Pelvic
      • Inguinal: Direct inguinal hernia
      • External/phallus: absence or loss of pubic hair; abnormally small phallus
      • Scrotal/testicular: undescended or absent testicle; absence of vas deferens; epididymal thickening or cyst; varicocele; indirect inguinal hernia

Management of Infertility

  • Investigations
    • Semen analysis: always get a semen analysis after the patient has abstained from coitus for 3 – 4 days. The sample should be obtained via masturbation without a condom and delivered to the lab within 1 hour
      • Azoospermia: absence of motile sperms
      • Oligozoospermia < 15 million per mL
      • Asthenozoospermia < 32% motile sperm
      • Teratozoospermia < 4% normal forms
    • Assess ovulatory function: Mid-luteal progesterone level or OTC urinary ovulation prediction kit
      • Abnormal mid-luteal progesterone levels = amenorrhoea
        • Serum prolactin
        • FSH
        • TSH
        • Assessment of PCOS (ultrasound)
    • Assessment of ovarian reserve: Day 3 FSH and estradiol levels should be ≤ 10 mIU/L)
      • Abnormal levels suggest menopause or premature ovarian failure
    • Hysterosalpingogram (HSG): evaluate the anatomy of the uterus and fallopian tubes using a dye. Performed as part of the initial workup or postponed until normal semen analysis and ovulation are confirmed
      • Tubal damage → Laparoscopy to further assess and attempt Tuboplasty
  • Treatment if semen analysis is abnormal
    • Assisted Reproductive Technology (ART)
      • Intrauterine insemination (IUI) – mild to moderate decreased density
      • Intracytoplasmic sperm injection followed by in vitro fertilization (ICSI + IVF) – severe abnormalities
      • Artificial insemination with donor sperm (AID) – absence of viable sperm
  • Treatment if the cause is anovulation
    • Correct the underlying cause (Hypothyroidism, hyperprolactinemia, or PCOS)
    • Ovarian Induction Therapy
      • Clomiphene citrate to induce ovulation – idiopathic or due to menopause/ovarian dysfunction
      • Human menopausal gonadotropin – second-line agent if Clomiphene fails. Carries a significant risk of multiple pregnancy
  • Treatment if there is tubal damage
    • Tuboplasty
    • In Vitro Fertilisation
  • Complications of Ovarian Induction Therapy
    • Ovarian Hyperstimulation Syndrome (OHSS): Swollen ovaries, ascites (high risk with gonadotropins/high estradiol)Multiple Pregnancy5–12% twins, 1% triplets+ (strict monitoring reduces risk)Ectopic Pregnancy: Slightly increased risk

Semen Analysis parameters

ParameterDescriptionNormal value
Sperm countNumber of sperm in the ejaculate≥ 15 million/ml
Total motilityProportion of sperm that can swim≥ 40%
Progressive motilityProportion of sperm swimming in one direction≥ 32%
MorphologySize and shape of sperm≥ 4% normal forms
VitalityProportion of sperm that are alive≥ 58%
Semen volumeAmount of semen produced≥ 1.5ml
White blood cellsIndicates infection< 1 million/ml
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team